These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23067912)

  • 1. Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with ST-segment elevation myocardial infarction.
    Lønborg J; Schoos MM; Kelbæk H; Holmvang L; Steinmetz J; Vejlstrup N; Jørgensen E; Helqvist S; Saunamäki K; Bøtker HE; Kim WY; Terkelsen CJ; Clemmensen P; Engstrøm T
    Am Heart J; 2012 Oct; 164(4):538-46. PubMed ID: 23067912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.
    Lønborg J; Vejlstrup N; Kelbæk H; Bøtker HE; Kim WY; Mathiasen AB; Jørgensen E; Helqvist S; Saunamäki K; Clemmensen P; Holmvang L; Thuesen L; Krusell LR; Jensen JS; Køber L; Treiman M; Holst JJ; Engstrøm T
    Eur Heart J; 2012 Jun; 33(12):1491-9. PubMed ID: 21920963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.
    Francone M; Bucciarelli-Ducci C; Carbone I; Canali E; Scardala R; Calabrese FA; Sardella G; Mancone M; Catalano C; Fedele F; Passariello R; Bogaert J; Agati L
    J Am Coll Cardiol; 2009 Dec; 54(23):2145-53. PubMed ID: 19942086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of left ventricular infarct transmurality and infarct size after primary percutaneous coronary angioplasty to time from symptom onset to balloon inflation.
    Hahn JY; Song YB; Gwon HC; Choe YH; Kim JH; Sung J; Choi SH; Choi JH; Kim DK; Hong KP; Park JE; Lee SH
    Am J Cardiol; 2008 Nov; 102(9):1163-9. PubMed ID: 18940285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study.
    Haeck JD; Kuijt WJ; Koch KT; Bilodeau L; Henriques JP; Rohling WJ; Baan J; Vis MM; Nijveldt R; van Geloven N; Groenink M; Piek JJ; Tijssen JG; Krucoff MW; De Winter RJ
    Heart; 2010 Feb; 96(3):190-5. PubMed ID: 19858136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ST-segment recovery on infarct size and ejection fraction in patients with ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention.
    Hallén J; Sejersten M; Johanson P; Atar D; Clemmensen PM
    Am J Cardiol; 2010 May; 105(9):1223-8. PubMed ID: 20403470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction.
    Ganame J; Messalli G; Dymarkowski S; Rademakers FE; Desmet W; Van de Werf F; Bogaert J
    Eur Heart J; 2009 Jun; 30(12):1440-9. PubMed ID: 19346229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia.
    Lønborg J; Kelbæk H; Vejlstrup N; Bøtker HE; Kim WY; Holmvang L; Jørgensen E; Helqvist S; Saunamäki K; Terkelsen CJ; Schoos MM; Køber L; Clemmensen P; Treiman M; Engstrøm T
    Circ Cardiovasc Interv; 2012 Apr; 5(2):288-95. PubMed ID: 22496084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of ST-segment elevation before and after percutaneous transluminal coronary angioplasty to left ventricular area at risk, myocardial infarct size, and systolic function.
    Rodríguez-Palomares JF; Figueras-Bellot J; Descalzo M; Moral S; Otaegui I; Pineda V; Del Blanco BG; González-Alujas MT; Evangelista Masip A; García-Dorado D
    Am J Cardiol; 2014 Feb; 113(4):593-600. PubMed ID: 24484860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction.
    Mills JS; Mahaffey KW; Lokhnygina Y; Nicolau JC; Ruzyllo W; Adams PX; Todaro TG; Armstrong PW; Granger CB;
    Coron Artery Dis; 2012 Mar; 23(2):118-25. PubMed ID: 22217457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial).
    Brodie BR; Webb J; Cox DA; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Dulas D; Rutherford B; Antoniucci D; Stuckey T; Krucoff M; Gibbons R; Lansky A; Na Y; Mehran R; Stone GW;
    Am J Cardiol; 2007 Jun; 99(12):1680-6. PubMed ID: 17560875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Ndrepepa G; Tiroch K; Keta D; Fusaro M; Seyfarth M; Pache J; Mehilli J; Schömig A; Kastrati A
    Circ Cardiovasc Interv; 2010 Feb; 3(1):27-33. PubMed ID: 20118156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Minimum salvaged myocardium after rescue percutaneous coronary intervention: quantification by cardiac magnetic resonance].
    Ruiz-Nodar JM; Feliu E; Sánchez-Quiñones J; Valencia-Martín J; García M; Pineda J; Martín P; Mainar V; Bordes P; Heras S; Quintanilla MA; Sogorb F
    Rev Esp Cardiol; 2011 Nov; 64(11):965-71. PubMed ID: 21784571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
    Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct.
    Pride YB; Giuseffi JL; Mohanavelu S; Harrigan CJ; Manning WJ; Gibson CM; Appelbaum E
    Am J Cardiol; 2010 Sep; 106(5):635-40. PubMed ID: 20723637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ST-segment resolution assessed immediately after primary percutaneous coronary intervention correlates with infarct size and left ventricular function in cardiac magnetic resonance at 1-year follow-up.
    Rakowski T; Dziewierz A; Siudak Z; Mielecki W; Brzozowska-Czarnek A; Legutko J; Rzeszutko L; Urbanik A; Dubiel JS; Dudek D
    J Electrocardiol; 2009; 42(2):152-6. PubMed ID: 19167012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
    Marso SP; Miller T; Rutherford BD; Gibbons RJ; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Mehran R; Krucoff MW; Lansky AJ; Stone GW
    Am J Cardiol; 2007 Jul; 100(2):206-10. PubMed ID: 17631071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Hahn JY; Kim HJ; Choi YJ; Jo SH; Kim HJ; Lee S; Ahn KJ; Song YB; Choi JH; Choi SH; Choi YJ; Lee KH; Lee SH; Gwon HC
    Am Heart J; 2011 Dec; 162(6):1026-33. PubMed ID: 22137076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.